Mikhna M G, Miroshnichenko I V, Nikonova M F, Aknazarova R Kh, Iarilin A A
Biull Eksp Biol Med. 1988 Feb;105(2):189-91.
Tactivin, the thymic hormone preparation, evokes some phenotype alterations in T-cell precursors (elimination of SC-1 antigen and expression of Thy-1-antigen) and cortical thymocytes (a decrease in the number of thymocytes carrying PNA-receptor) similar to those arising in T-cell differentiation. Tactivin induces PNA+ -thymocyte response to PHA action and increases PHA response to PNA- -thymocytes. It is weakly mitogenic for T-cell precursors and PNA- -thymocytes. The data suggest that Tactivin may be used for the treatment of immune deficiencies with T-cell differentiation and function defects.
促活素,这种胸腺激素制剂,会引起T细胞前体(SC-1抗原消失和Thy-1抗原表达)以及皮质胸腺细胞(携带PNA受体的胸腺细胞数量减少)出现一些表型改变,类似于T细胞分化过程中出现的改变。促活素诱导PNA+胸腺细胞对PHA作用产生反应,并增强PHA对PNA-胸腺细胞的反应。它对T细胞前体和PNA-胸腺细胞的促有丝分裂作用较弱。这些数据表明,促活素可用于治疗存在T细胞分化和功能缺陷的免疫缺陷症。